Onconetix, INC. (ONCO) — S-1/A Filings

All S-1/A filings from Onconetix, INC.. Browse 6 S-1/A reports with AI-powered summaries and risk analysis.

S-1/A Filings (6)

Onconetix Shifts Focus to Prostate Cancer Diagnostic, Dumps BPH Drug — Dec 22, 2025 Risk: high
Onconetix, Inc. (ONCO) filed an S-1/A on December 22, 2025, registering 29,778,195 shares of common stock for resale by Selling Stockholders. This includes up t
Onconetix, Inc. Files S-1/A Amendment — Feb 7, 2025 Risk: medium
Onconetix, Inc. filed an S-1/A amendment on February 7, 2025, for its initial public offering. The company, formerly known as Blue Water Biotech, Inc. and Blue
Onconetix, Inc. Files S-1/A Amendment No. 3 — Dec 11, 2024 Risk: medium
Onconetix, Inc. (formerly Blue Water Biotech, Inc.) filed an S-1/A amendment on December 11, 2024, for its registration statement. The company, incorporated in
Onconetix, Inc. Files S-1/A Amendment for IPO — Nov 12, 2024 Risk: medium
Onconetix, Inc. filed an S-1/A amendment on November 12, 2024, for its initial public offering. The company, formerly known as Blue Water Biotech, Inc. and Blue
Onconetix, Inc. Files S-1/A Amendment — Jun 25, 2024 Risk: medium
Onconetix, Inc. filed an S-1/A amendment on June 24, 2024, for its registration statement. The company, formerly known as Blue Water Biotech, Inc. and Blue Wate
Onconetix, Inc. Files S-1/A Amendment — Jun 5, 2024 Risk: medium
Onconetix, Inc. filed an S-1/A amendment on June 4, 2024, for its registration statement. The company, formerly known as Blue Water Biotech, Inc. and Blue Water

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX